San Francisco, CA, United States of America

Leonard G Presta

USPTO Granted Patents = 211 

 

Average Co-Inventor Count = 2.7

ph-index = 58

Forward Citations = 16,755(Granted Patents)


Inventors with similar research interests:


Location History:

  • San Francsico, CA (US) (1998 - 2000)
  • South San Francisco, CA (US) (2004 - 2014)
  • Palo Alto, CA (US) (2017)
  • La Jolla, CA (US) (2021)
  • San Francisco, CA (US) (1992 - 2024)
  • Burlingame, CA (US) (2020 - 2024)

Company Filing History:

goldMedal121 out of 3,221 
 
Genentech, Inc.
 patents
silverMedal16 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal15 out of 1,829 
 
Schering Corporation
 patents
410 out of 60 
 
Compugen Ltd. Corporation
 patents
59 out of 20 
 
Igm Biosciences, Inc.
 patents
65 out of 266 
 
Pierre Fabre Medicament
 patents
75 out of 5 
 
Pionyr Immunotherapeutics, Inc.
 patents
84 out of 98 
 
Genetech, Inc.
 patents
93 out of 56 
 
Zymeworks Inc.
 patents
103 out of 1,186 
 
The Scripps Research Institute
 patents
112 out of 245 
 
Intervet Inc.
 patents
122 out of 3 
 
Angiex, Inc.
 patents
132 out of 2 
 
Biograph 55, Inc.
 patents
142 out of 2 
 
Relinia, Inc.
 patents
152 out of 919 
 
Gilead Sciences, Inc.
 patents
162 out of 2 
 
Portsmouth Merger Sub Ii, LLC
 patents
171 out of 132 
 
Seattle Genetics, Inc.
 patents
181 out of 2 
 
Igm Biosciences A/s
 patents
191 out of 196 
 
Alexion Pharmaceuticals, Inc.
 patents
201 out of 17 
 
Zymeworks Bc Inc.
 patents
211 out of 1 
 
Ptm Therapeutics, Inc.
 patent
221 out of 17 
 
Cellerant Therapeutics, Inc.
 patents
231 out of 216 
 
Xencor, Inc.
 patents
241 out of 832,680 
Other
 patents

Years Active: 1992-2025

Loading Chart...
Loading Chart...
211 patents (USPTO):

Title: Leonard Presta - Pioneering Innovator with 156 Patents

Introduction:

Leonard Presta, an accomplished inventor and innovator based in San Francisco, CA, has made significant contributions to the field of biotechnology. With a remarkable portfolio of 156 patents to his name, Presta has revolutionized various aspects of antibody engineering. This article explores his latest patents, career highlights, collaborations, and affirms his status as a trailblazer in the industry.

Latest Patents:

Among Leonard Presta's recent patents, two remarkable innovations stand out. The first is related to anti-TIGIT antibodies, which are designed to enhance the effectiveness of immunotherapies. These antibodies target TIGIT, a protein that suppresses immune response, thus contributing to the fight against cancer and other diseases. The second patent focuses on binding molecules with modified J-chain, which includes an antibody variant capable of inhibiting T-cell inhibitory signaling pathways. This breakthrough has potential applications in immunotherapy and personalized medicine.

Career Highlights:

Leonard Presta has held key positions in prestigious biotechnology companies, where he has made remarkable contributions to research and development. Notably, he has worked at Genentech, Inc., a leading biotechnology corporation known for its groundbreaking medical solutions. His expertise has also been utilized at the Schering Corporation, a renowned pharmaceutical company. Presta's patents and inventions have played a significant role in driving the success and advancement of these organizations.

Collaborations:

Throughout his career, Leonard Presta has collaborated with esteemed individuals and scientists in his field. One of his notable collaborators is Henry Bernard Lowman, an experienced researcher who shares Presta's passion for antibody engineering. Together, they have worked on various projects, contributing to the advancement of biotechnology. Additionally, Presta has collaborated with Napoleone Ferrara, a distinguished name in the field of cancer research and the development of anti-angiogenesis therapy. These collaborations underline Presta's commitment to pushing boundaries and fostering innovation through shared expertise.

Conclusion:

Leonard Presta's extensive patent portfolio and career highlights attest to his immense contributions in the field of biotechnology and antibody engineering. Through his groundbreaking inventions, such as the anti-TIGIT antibodies and modified J-chain binding molecules, Presta has paved the way for improved immunotherapies and personalized medicine. His work at influential companies like Genentech, Inc. and collaborations with esteemed researchers further underline his role as an invaluable pioneer in the industry. Leonard Presta’s dedication to innovation and exemplary contributions continue to shape the landscape of biotechnology and inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…